About (ACB) Aurora Cannabis Inc.

Company Background

Aurora Cannabis Inc., symbol ACB on the Toronto Stock Exchange (TSX) and Nasdaq, is a leading Canadian licensed producer of medical and recreational cannabis. Founded in 2013 and headquartered in Edmonton, Alberta, Aurora has grown into one of the most recognized names in the global cannabis industry. The company operates multiple state-of-the-art cultivation and production facilities across Canada and Europe, with a strong emphasis on pharmaceutical-grade cannabis and research-driven innovation. Aurora’s diverse product portfolio includes dried flower, oils, edibles, concentrates, and medical-grade products, catering to both individual consumers and healthcare professionals. Its mission is to improve lives through the science of cannabis and responsible product development.

Market Position

Aurora Cannabis holds a leading position in Canada’s cannabis market and maintains an expanding presence in international medical cannabis markets, including Germany, Australia, and Israel. The company’s vertically integrated operations—from cultivation and processing to distribution—enable efficient production and consistent quality. Aurora’s strategic focus on the premium and medical segments differentiates it from competitors, emphasizing high-margin, science-based products. Its continued investment in clinical research and pharmaceutical partnerships supports the growing acceptance of medical cannabis globally. In the recreational segment, Aurora’s strong brand portfolio, including San Rafael ’71 and Daily Special, ensures a solid foothold among Canadian consumers.

Key Financial and Industry Highlights

Aurora’s financial performance reflects the cannabis industry’s evolution, characterized by consolidation, regulation, and increasing global demand. The company has implemented a disciplined cost-reduction strategy, improved operational efficiency, and focused on sustainable profitability. Recent financial restructuring and strategic divestments have strengthened its balance sheet, allowing Aurora to concentrate on its core medical and premium cannabis businesses. With growing international exports and a strong medical pipeline, the company is positioned to benefit from the rising global acceptance of cannabis for therapeutic and wellness purposes.

As a pioneer in cannabis innovation, Aurora continues to leverage advanced genetics, precision cultivation, and pharmaceutical partnerships to enhance product quality and expand its market share. Its commitment to science, safety, and sustainability underscores its long-term vision to be a global leader in the cannabis and wellness industries. With a renewed focus on profitability and international growth, Aurora Cannabis remains a key player in shaping the future of the global cannabis market.